Michael Aviram

1.1k total citations
13 papers, 914 citations indexed

About

Michael Aviram is a scholar working on Biochemistry, Surgery and Immunology. According to data from OpenAlex, Michael Aviram has authored 13 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biochemistry, 7 papers in Surgery and 6 papers in Immunology. Recurrent topics in Michael Aviram's work include Antioxidant Activity and Oxidative Stress (8 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Cholesterol and Lipid Metabolism (5 papers). Michael Aviram is often cited by papers focused on Antioxidant Activity and Oxidative Stress (8 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Cholesterol and Lipid Metabolism (5 papers). Michael Aviram collaborates with scholars based in Israel. Michael Aviram's co-authors include Bianca Fuhrman, Jacob Vaya, Irit Maor, Mira Rosenblat, Paula A. Belinky, Aaron Hoffman, Marielle Kaplan, A Etzioni, Rachel Lévy and Saeed Mahmood and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and Atherosclerosis.

In The Last Decade

Michael Aviram

13 papers receiving 857 citations

Peers

Michael Aviram
Michael Aviram Israel
Bhavani Prasad Kota Australia
Elango Bhakkiyalakshmi India
Inmaculada Concepción Villar United Kingdom
Florina Andrica Romania
Feihua Wu China
Jarinyaporn Naowaboot Thailand
Yuguang Lin Netherlands
Valérie B. Schini-Kerth France
Abdellatif Settaf Morocco
Michael Aviram Israel
Michael Aviram
Citations per year, relative to Michael Aviram Michael Aviram (= 1×) peers Michael Aviram

Countries citing papers authored by Michael Aviram

Since Specialization
Citations

This map shows the geographic impact of Michael Aviram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aviram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aviram more than expected).

Fields of papers citing papers by Michael Aviram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Aviram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aviram. The network helps show where Michael Aviram may publish in the future.

Co-authorship network of co-authors of Michael Aviram

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Aviram. A scholar is included among the top collaborators of Michael Aviram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Aviram. Michael Aviram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Aviram, Michael, et al.. (2005). Macrophage-foam cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose. Atherosclerosis. 183(1). 25–33. 45 indexed citations
2.
3.
Vaya, Jacob, et al.. (2001). Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radical Research. 34(5). 485–497. 104 indexed citations
4.
Fuhrman, Bianca & Michael Aviram. (2001). Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Current Opinion in Lipidology. 12(1). 41–48. 231 indexed citations
5.
Maor, Irit, et al.. (2000). Oxidized Monocyte-Derived Macrophages in Aortic Atherosclerotic Lesion from Apolipoprotein E-Deficient Mice and from Human Carotid Artery Contain Lipid Peroxides and Oxysterols. Biochemical and Biophysical Research Communications. 269(3). 775–780. 71 indexed citations
6.
Belinky, Paula A., Michael Aviram, Bianca Fuhrman, Mira Rosenblat, & Jacob Vaya. (1998). The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis. 137(1). 49–61. 140 indexed citations
7.
Fuhrman, Bianca, et al.. (1997). Increased Uptake of LDL by Oxidized Macrophages is the Result of an Initial Enhanced LDL Receptor Activity and of a Further Progressive Oxidation of LDL. Free Radical Biology and Medicine. 23(1). 34–46. 61 indexed citations
8.
Aviram, Michael, et al.. (1996). Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein. Metabolism. 45(9). 1069–1079. 90 indexed citations
9.
Aviram, Michael & Irit Maor. (1992). Phospholipase A2-modified LDL is taken up at enhanced rate by macrophages. Biochemical and Biophysical Research Communications. 185(1). 465–472. 46 indexed citations
10.
Keidar, Shlomo, Marielle Kaplan, Mira Rosenblat, Gerald J. Brook, & Michael Aviram. (1992). Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL. Metabolism. 41(11). 1185–1192. 22 indexed citations
11.
Fuhrman, Bianca, Gerald J. Brook, & Michael Aviram. (1992). Proteins derived from platelet α granules modulate the uptake of oxidized low density lipoprotein by macrophages. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1127(1). 15–21. 19 indexed citations
12.
Aviram, Michael, Uri Cogan, & Shoshana Mokady. (1991). Excessive dietary tryptophan enhances plasma lipid peroxidation in rats. Atherosclerosis. 88(1). 29–34. 29 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Aviram Breakdown of academic impact, for papers by Bhavani Prasad Kota Breakdown of academic impact, for papers by Elango Bhakkiyalakshmi Breakdown of academic impact, for papers by Inmaculada Concepción Villar Breakdown of academic impact, for papers by Florina Andrica Breakdown of academic impact, for papers by Feihua Wu Breakdown of academic impact, for papers by Jarinyaporn Naowaboot Breakdown of academic impact, for papers by Yuguang Lin Breakdown of academic impact, for papers by Valérie B. Schini-Kerth Breakdown of academic impact, for papers by Abdellatif Settaf
Rankless by CCL
2026